Answered step by step
Verified Expert Solution
Link Copied!

Question

1 Approved Answer

General Optic Corporation operates a manufacturing plant in Arizona. Due to a significant decline in demand for the product manufactured at the Arizona site, an

General Optic Corporation operates a manufacturing plant in Arizona. Due to a significant decline in demand for the product manufactured at the Arizona site, an impairment test is deemed appropriate. Management has acquired the following information for the assets at the plant:

Cost $ 39,500,000
Accumulated depreciation 14,900,000

Generals estimate of the total cash flows to be generated by selling the products manufactured at its Arizona plant, not discounted to present value

16,400,000

The fair value of the Arizona plant is estimated to be $14,500,000.

Required:
1.

Determine the amount of impairment loss. (Enter your answer in whole dollars.)

2.

If a loss is indicated, where would it appear in General Optics multiple-step income statement?

Operating expenses
Non-operating expenses

3. If a loss is indicated, prepare the entry to record the loss. (If no entry is required for an event, select "No journal entry required" in the first account field. Enter your answers in whole dollars.)

4.

Determine the amount of impairment loss assuming that the estimated undiscounted sum of future cash flows is $15,500,000 instead of $16,400,000. (Enter your answer in whole dollars.)

5.

Determine the amount of impairment loss assuming that the estimated undiscounted sum of future cash flows is $24,850,000 instead of $16,400,000

Step by Step Solution

There are 3 Steps involved in it

Step: 1

blur-text-image

Get Instant Access to Expert-Tailored Solutions

See step-by-step solutions with expert insights and AI powered tools for academic success

Step: 2

blur-text-image

Step: 3

blur-text-image

Ace Your Homework with AI

Get the answers you need in no time with our AI-driven, step-by-step assistance

Get Started

Recommended Textbook for

New Principles Of Best Practice In Clinical Audit

Authors: Robin Burgess

2nd Edition

1138443646, 978-1138443648

More Books

Students also viewed these Accounting questions